The market for peptide therapeutics is anticipated to expand at a CAGR of 10.5% during the forecast period of 2024 and 2032, propelled by innovative research, the rising prevalence of chronic diseases, and an emphasis on personalized medicine. Notwithstanding obstacles about expense and availability, the market demonstrates tenacity, propelled by a wide array of applications spanning various sectors. The segmentation ...
Read More »